Caplight Directory>Companies>Heqet Therapeutics-preview>Heqettherapeutics


Heqet Therapeutics

Heqet Therapeutics

Private
TorinoHealthcare & Life Scienceshttps://www.heqettherapeutics.com/

Last Round

Series A

Mar 23, 2022

Total Funding Raised

$8.7M

Company Overview

Heqet Therapeutics is a biotechnology company that develops non-coding RNA-based therapies for cardiovascular diseases, with a particular emphasis on acute myocardial infarction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

cardiac regenerationnon-coding RNA therapyncRNA therapymicroRNA therapymiRNA therapyLNP deliverylipid nanoparticlesheart attack therapyheart repairRNA therapeuticsregenerative medicinemyocardial infarctionpreclinical biotechcardiomyocyte proliferationheart failure therapydrug discoverymyocardial delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Heqet Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Heqet Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 23, 2022
View all Funding Rounds

Heqet Therapeutics Investors

Notable investors and investment history

InvestorRounds
Deutsche BalatonSeries A
Claris VenturesSeries A
2invest AGSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Monthly visitors grew 122% MoM, reaching 1.1K.

  • Nov 18, 2024

    Monthly visitors increased 45% MoM.

View all signals

Heqet Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Heqet Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Heqet Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersTorino
Employee Range2
Year Founded2021
Last FundingMar 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.